Clinic to Serve as rEEG(R) 'Center of Excellence' Advancing Performance in

Patient Outcomes, Costs and Convenience

COSTA MESA, Calif., Jan. 15 /PRNewswire-FirstCall/ -- CNS Response,
Inc. (OTC Bulletin Board: CNSO) announced today that it has completed the
previously announced acquisition of Neuro-Therapy Clinic, P.C., a
neuropsychiatric clinic in Denver, Colorado. The Company also announced
that Daniel A. Hoffman, MD has been appointed Chief Medical Officer. Dr.
Hoffman, a neuropsychiatrist with more than 25 years experience, was
previously National Medical Director of Neuro-Therapy Clinic.

Len Brandt, Chairman and CEO of CNS Response, reported, "Our close
relationship with Dr. Hoffman and the Neurotherapy Clinic has already
played a significant role in establishing the value of rEEG(R) guidance in
medication management."

George Carpenter, President of CNS Response, commenting on the future,
said, "We expect Neuro-Therapy Clinic to further define the opportunity to
use technology in general, and rEEG in particular, to vastly improve clinic
performance in patient outcomes, costs, and convenience and to best
communicate this to all -- patient, physician, payer. In this way, the
Neuro-Therapy Clinic is something of a dynamic laboratory discovering how
to integrate technology and be a true center of excellence on all of these
measures. Put to practice, this knowledge presents CNS Response with an
opportunity to further our relationship with other clinics and physicians
using rEEG."

"Dr. Hoffman is a leader and a true partner in the development of rEEG
so we are particularly pleased to have him join our team," Mr. Brandt
continued. "Dr. Hoffman will play a critical role in implementing our
strategy for the validation and commercialization of our core rEEG
platform."

Established in 1993, Neuro-Therapy Clinic, P.C. is a center for
highly-advanced testing and treatment of neuropsychiatric problems,
including learning, attentional and behavioral challenges, mild head
injuries, as well as depression, anxiety, bipolar and all other common
psychiatric disorders.

Dr. Hoffman served as Medical Director for Neuro-Therapy Clinic from
1993-2007. He also served as National Medical Director for CNS Response
from 2004-2007 and has maintained a private practice in neuropsychiatry
since 1977. He served as an Assistant Clinical Professor at the University
of Colorado from 1977 to 1996.

Dr. Hoffman has lectured extensively throughout the country on
leading-edge testing and treatment for Psychiatric Medication Selection and
other brain related topics and has been published in more than 30
peer-reviewed articles. He is on the editorial boards of the Journal of
Neurotherapy, the Journal of Applied Psychophysiology and Self Regulation
and the Journal of Neuropsychiatry and Clinical Neurosciences.

About CNS Response

CNS Response is a life-sciences data company focused on the
commercialization of the first patented commercial system that guides
psychiatrists and other physicians to determine proper treatments for
patients with behavioral (mental or addictive) disorders. This technology
allows CNS Response to create and provide simple reports ("rEEG(R)
Reports") that specifically guide physicians to treatment strategies based
on the patient's own physiology.

rEEG(R) utilizes traditional electroencephalography (EEG) in
conjunction with a normative database and a proprietary clinical
(symptomatic) database to identify the following: (1) medication classes
most likely to be needed; and (2) medications within these classes with the
most probable treatment potential for each patient. Reports are provided to
physicians in a relationship analogous to that of a reference laboratory.
Prospective, retrospective and field studies of treatment-resistant
patients have reported treatment success of 70% or greater in managed care,
outpatient psychiatric and residential substance abuse clinical settings.

In addition to providing analytical support to physicians, CNS Response
is also an aide to pharmaceutical developers, who can use rEEG to (1)
stratify study populations to improve the success of FDA clinical trials;
(2) provide insight on effective therapeutic dosing of investigational
drugs; (3) identify additional indications for psychiatric medications; (4)
provide insight into effective drug combinations; and (5) discover
opportunities for decision analytics and support. In addition to these
applications, CNS Response continues to investigate the use of rEEG
analysis for development of proprietary pharmaceutical opportunities.

Except for the historical information contained herein, the matters
discussed are forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995, as
amended. These statements involve risks and uncertainties as set forth in
the Company's filings with the Securities and Exchange Commission. These
risks and uncertainties could cause actual results to differ materially
from any forward-looking statements made herein.

(Date:10/12/2017)... ... October 12, 2017 , ... ... genomics analysis platform specifically designed for life science researchers to analyze and ... researcher Rosalind Franklin, who made a major contribution to the discovery of ...

(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...

(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...

(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...